We recently published a commentary in Public Health Open Journal regarding Bromazolam (fake Xanax) use. It is increasingly being found in the illicit drug supply, mixed with other drugs like fentanyl and heroin, among others. Within the commentary, we examine the current state of the science as it pertains to the public health dangers of Bromazolam and its various illicit distribution networks, not only in North America but across the world. We also examine possible directions the substance use disorder (SUD) field may undertake to address the proliferation and abuse of this substance along with overdose prevention efforts that include the public health dangers of Bromazolam use.
We invite you to download this free commentary to read and share with your friends, family, and colleagues.
Xylazine is a significant drug used by veterinarians specializing in the care of large animals such as horses, cattle, and deer as it provides needed pain relief. Despite this usefulness, as often happens with legal drug supplies, illicit uses become commonplace and result in unintended consequences—in this case, devastating ones. In our new peer reviewed article we examine the current state of the science as pertains to xylazine and the various uses of the illicit supply line, as well as exploring possible answers to directions the substance use disorder field may have at their disposal to address this ever-mounting set of calamitous circumstances. In addition, we provide possible directions on what next steps may be appropriate to address these multiple dangers.
We invite you to read and share the paper with your colleagues.
The behavioral survey looks at any mental illness, serious mental illness, major depressive episodes, co-occurring AMI and SUD, suicidal thoughts, plans and attempts.
The substance use survey covers cigarette smoking, alcohol use, binge drinking, heavy alcohol drinking, illicit drug use, marijuana use, CNS, stimulants, cocaine, Rx stimulants, meth, opioids, inhalants, etc.
Women often remain under the radar in terms of substance use even now, but the stats on Lesbians and Bisexual women might surprise you so take a look.
The report is straight forward which means an easy and fast read.
Overall, the SASSI can be a valuable tool for helping members of the LGBTQIA+ community by identifying and addressing substance use disorders. It can provide a standardized and sensitive way to screen for these issues and can help to ensure that individuals receive appropriate care and support based on their unique needs and experiences.
On January 19th of this year our latest manuscript was published in Social Behavior Research and Practice. Examining Sustained Recovery from Substance Use Disorder — A Delicate Process discusses the various aspects and definitional terms involved in achieving sustained abstinence (Long-term recovery). This article was submitted as the first in a series of manuscripts examining the recovery process; both from the perspective of the recovering individual, but also including persons within that individual’s personal and professional circles. Our goal is to achieve a holistic understanding of recovery as experienced and understood by recovering individuals, but in addition, to achieve a better understanding of what that recovery experience looks like from the perspective of those with direct access to the individual’s recovery sphere. We are actively seeking collaborations with substance use programs, outpatient clinics, halfway houses, and other venues where individuals undergoing their personal recovery experience may be residing or whose service they may be utilizing. We firmly believe in the adage that there can be “Nothing about us without us,” (Jürgens R., 2008). Please help us accomplish what promises to be an exciting and fruitful undertaking as we seek to quell the ongoing ravages of addiction in its many forms.
The SASSI Institute recently published an article in Women’s Health on early intervention and resources for expectant mothers with substance use problems and service shortages in the present age. Within it, we discuss the need for more research and collaboration in regards to substance use disorder and criminal Justice, especially to assist women avoid the stigmatization and ostracizing they may experience; many simply by virtue of having experienced the disease of addiction. When combined with the criminalization of drug use, society inevitably finds itself entrapping these women in a revolving door fed by the “drug-crime” connection, but now also including newborns. Babies should NOT be born in prison, especially sick babies; however, when they are, quality prenatal care, early intervention, and community support upon release from prison are imperative to help those babies and their mothers have positive long-term outcomes. Please consider this a call to action, we welcome your interest in collaborative efforts.
Now in its fourth iteration (SASSI-4), this article discusses the SASSI screening tools’ utility with criminal offenders and reviews a case study of a young male’s clinical evaluation while incarcerated. While SUD is not the only contributing factor to criminality, it significantly increases the likelihood of legal infraction and violations, placing these individuals at a higher risk of re-offending. Thus, identifying SUD as early as possible in the clinical relationship helps provide tailored treatment to those who need it, while simultaneously reducing the risk of future legal difficulties.
For this case study, we reviewed the SASSI-4 screening results of a 24-year-old male. The case presents an excellent example of the value of early identification of substance use disorder and potential problems in criminal justice settings.
We hope you enjoy the article, and as always, we look forward to your submissions and comments.
The SASSI Institute is pleased to announce the publication of its newest manuscript “Mental Health and Substance Use Disorder Co-Morbidities Among Teens in Treatment: SASSI-A3 Correlations in Screening Scores.” Within this article, we review data from teenagers in treatment focusing on mental health diagnoses alongside a DSM-5 diagnosis of substance use disorder. Our hope is that by identifying possible correlations between SASSI-A3 scale scores and diagnosed mental health disorders, (depression and anxiety in particular), will provide clinicians with additional tools to direct the course of subsequent clinical interviews, in particular for teens suffering from co-occurring disorders. This Open-Access article is available here: Mental Health and Substance Use Disorder Co-Morbidities Among Teens in Treatment: SASSI-A3 Correlations in Screening Scores
On Monday, November 9th,the CEO of Pfizer announced positive early results from its coronavirus vaccine trial, citing an over 90% effectiveness rate during its first phase of clinical trials. This is truly monumental news of worldwide significance. This fact has renewed hope throughout the country, indeed throughout the world, that we were finally coming closer to achieving a response to this deadly Pandemic. We at The SASSI Institute maintain our fervent hopes that in light of the over 100,000 daily national cases that have now become the norm, as a country and internationally, we will soon be able to eradicate this unfathomably terrible disease.
Given the recent spikes, like so many other businesses throughout the country, we recently had to again minimize our in-office time for all staff, including our shipping department. Nevertheless, all of our departments are open for business, and we want to reassure you that we will ship your products out on time, and as promised. We also want to remind you that we maintain our schedule of a December 1st SASSI Adolescent-3 release and that we have several articles in submission while we await their scientific review. Please contact our Customer Service team for pre-ordering information, and/or our Training Department for our upcoming training schedules.
I am delighted to announce that our Board of Directors and management team want to assure you that given this calamitous year, and in the hopes of giving our customer base a hand-up, we will not be raising prices in 2021. In fact, if you are experiencing financial difficulties, please contact our Customer Service Team and/or our Training team. They are more than willing to make suitable payment arrangements and offer their assistance during these difficult times.
We sincerely hope that you, your families, and colleagues remain safe. We remain confident that better times lie ahead!
It is with great pride that we announce the release of our latest adolescent research manuscript. This article is based on one key aspect of the Substance Abuse Subtle Screening Inventory (SASSI) Institute’s forthcoming third iteration of the Adolescent Substance Abuse Subtle Screening Inventory (SASSI-A3). While our primary goal was to develop a screening tool for adolescents that is concordant with the diagnostic and statistical manual of mental disorders, Fifth Edition (DSM-5) guidelines, we found other aspects of the instrument that we felt were beneficial to investigate further. This article, Vaping and Edibles: Self-Reported Usage Patterns Among Teens In and Out of Treatment, focuses on questions regarding cannabidiol (CBD) edible consumption and the extent of vaping to review and subsequently address these dangers in teens.
Teens that begin using alcohol, drugs, and tobacco early in adolescence are more likely to engage in vaping and edible usage. They are also more likely to use at a more frequent rate. Early intervention is a critical component towards preventing possible negative outcomes for substance misusing teens. Identifying these patterns will inevitably direct the course of subsequent clinical interviews and treatment planning.
